Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Residual Asthma Exacerbations on Biologics Vary by Mechanism

Published Date: 13 Oct 2026

Residual Asthma Exacerbations on Biologics Vary by Mechanism

Phase 4 THRIVE Data Highlights Eptinezumab’s Impact on Migraine After Prior CGRP Failure Marco Meglio

Published Date: 13 Oct 2026

Newly announced Phase 4 THRIVE trial results showed most patients who previously had an inadequate response to a CGRP-targeting therapy improved with eptinezumab over 24 weeks.

FDA Action Update, September 2026: Approvals, Clearances, and Priority Review Isabella Ciccone, MPH

Published Date: 13 Oct 2026

Catch up on any of the neurology headlines you may have missed in September 2026, compiled into 1 place by the NeurologyLive® team.

Same PFAS Metabolites Tied to Maternal IBD Linked to Child Calprotectin Elizabeth Spencer, MD, MS

Published Date: 13 Oct 2026

Elizabeth Spencer, MD, discusses new data from 3 birth cohorts linking PFAS metabolites tied to maternal IBD to elevated calprotectin in children.

Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

Published Date: 13 Oct 2026

Jordan Axelrad, MD, MPH, discusses first-line IBD therapy selection, sequencing after failure, treat-to-target monitoring, and evaluating new agents

When IBD Symptoms Don't Match Inflammation, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

Published Date: 13 Oct 2026

A gastroenterologist explains why IBD symptoms don't always signal a flare, the biomarkers used to confirm inflammation, and counseling patients through Crohn's disease.

ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis

Published Date: 13 Oct 2026

ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis

Nemolizumab Sustains AD Response at 3 Years, With Matthias Augustin, MD Matthias Augustin, MD

Published Date: 13 Oct 2026

Up to 91% of patients reached EASI-75 at week 152 in the ARCADIA LTE, with consistent safety and gains in itch and quality of life.

Denifanstat Sustains Acne Improvement Through 52 Weeks in Phase 3 Extension

Published Date: 13 Oct 2026

Denifanstat Sustains Acne Improvement Through 52 Weeks in Phase 3 Extension

Knowledge Hub

Oncology

Pediatric Cancer Organoid Biobanks and Quality Standards

Comprehensive review of pediatric cancer organoid biobanks, focusing on quality standards and clinical applications.

Oncology

Fertility Preservation Considerations Before Hematologic Cancer Therapy

Comprehensive review of fertility preservation strategies before hematologic cancer therapy for healthcare professionals.

Oncology

Digital Specimen Tracking for Precision Oncology Workflows

Comprehensive review of digital specimen tracking systems in precision oncology workflows for improved diagnostic accuracy and patient safety.

Oncology

Wearable Sensors for Detecting Early Lymphedema Changes

Comprehensive review of wearable sensor technology for early detection of lymphedema in clinical practice.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Residual Asthma Exacerbations on Biologics Vary by Mechanism

Phase 4 THRIVE Data Highlights Eptinezumab’s Impact on Migraine After Prior CGRP Failure Marco Meglio

FDA Action Update, September 2026: Approvals, Clearances, and Priority Review Isabella Ciccone, MPH

Same PFAS Metabolites Tied to Maternal IBD Linked to Child Calprotectin Elizabeth Spencer, MD, MS

Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

When IBD Symptoms Don't Match Inflammation, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis

Nemolizumab Sustains AD Response at 3 Years, With Matthias Augustin, MD Matthias Augustin, MD

Denifanstat Sustains Acne Improvement Through 52 Weeks in Phase 3 Extension

Knowledge Hub

Pediatric Cancer Organoid Biobanks and Quality Standards

Fertility Preservation Considerations Before Hematologic Cancer Therapy

Digital Specimen Tracking for Precision Oncology Workflows

Wearable Sensors for Detecting Early Lymphedema Changes

Toxicity Surveillance for Bispecific Cancer Therapies

Case-Based Learning: Cancer-Associated Thrombosis During Noncytotoxic Therapy

Pharmacokinetic Optimization of Combination Cancer Therapy

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Residual Asthma Exacerbations on Biologics Vary by Mechanism

Phase 4 THRIVE Data Highlights Eptinezumab’s Impact on Migraine After Prior CGRP Failure Marco Meglio

FDA Action Update, September 2026: Approvals, Clearances, and Priority Review Isabella Ciccone, MPH

Same PFAS Metabolites Tied to Maternal IBD Linked to Child Calprotectin Elizabeth Spencer, MD, MS

Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

When IBD Symptoms Don't Match Inflammation, With Jordan Axelrad, MD, MPH Jordan Axelrad, MD, MPH

ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis

Nemolizumab Sustains AD Response at 3 Years, With Matthias Augustin, MD Matthias Augustin, MD

Denifanstat Sustains Acne Improvement Through 52 Weeks in Phase 3 Extension

Knowledge Hub

Pediatric Cancer Organoid Biobanks and Quality Standards

Fertility Preservation Considerations Before Hematologic Cancer Therapy

Digital Specimen Tracking for Precision Oncology Workflows

Wearable Sensors for Detecting Early Lymphedema Changes

Toxicity Surveillance for Bispecific Cancer Therapies

Case-Based Learning: Cancer-Associated Thrombosis During Noncytotoxic Therapy

Pharmacokinetic Optimization of Combination Cancer Therapy

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views